Patent Assignment
Reel/Frame 017480/0281
Release of Security Interest
Recorded: 2006-01-23
Received: 2006-01-25
Pages: 6
Assignor
SILICON VALLEY BANK
Executed: 2006-01-11
Assignee
MYOGEN, INC.
7575 W 103RD AVE., SUITE 102, WESTMINSTER, CO, 80021, UNITED STATES
Covered Properties
(8)
Expression profiling in the intact human heart
Application:
10/241,368 →
Transgenic Mice Comprising a Constitutively-Activated MEK5 and Exhibiting Cardiac Hypertrophy and Dilated Cardiomyopathy
Application:
10/159,971 →
Methods for preventing cardiac hypertrophy and heart failure by inhibition of MEF2 transcription factor inhibitor
Application:
10/043,658 →
Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
Application:
10/045,594 →
Diagnosis and Treatment of Myocardial Failure
Application:
09/969,086 →
Methods and Compositions for Stabilizing Microtubules and Intermediate Filaments in Striated Muscle Cells
Application:
09/908,988 →
Methods Relating to Muscle Selective Calcineurin Interacting Protein (Mcip)
Application:
09/782,953 →
Transgenic animal models for cardiac hypertrophy and methods of use thereof (screening)
Application:
09/772,503 →